Novo Nordisk slashes Wegovy, Ozempic prices starting in 2027

Evan Seigerman, managing director and head of healthcare research at BMO Capital Markets, joins BNN Bloomberg to discuss Novo Nordisk cutting prices on weight loss drugs. +++ Subscribe to BNN Bloomberg to watch more videos: https://www.youtube.com/BNNBloomberg Connect with BNN Bloomberg: For the latest news visit: https://www.bnnbloomberg.ca For a full video offering visit BNN Bloomberg: https://www.bnnbloomberg.ca/video BNN Bloomberg on Twitter: https://twitter.com/bnnbloomberg BNN Bloomberg on LinkedIn: https://www.linkedin.com/company/bnn-bloomberg -- BNN Bloomberg is Canada’s only TV service devoted exclusively to business, finance and the markets. #BNNBloomberg #Canadiannews #Businessnews